Alvotech (ALVO) Shares Outstanding (Weighted Average) (2020 - 2025)

Alvotech (ALVO) reported Shares Outstanding (Weighted Average) of $2.9 million for Q4 2025, down 99.03% on a YoY basis from $301.8 million in Q4 2024, and down 99.86% quarter-over-quarter from $2.1 billion in Q3 2025.

Alvotech (ALVO) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends

Alvotech has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $2.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) fell 99.03% year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2025 stood at $2.9 million (down 99.03% YoY), and the FY2025 full-year result was $2.9 million, down 99.03% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $2.9 million, down from $2.1 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $2.1 billion in Q3 2025, with the low at $390.0 in Q2 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2022.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) sank 100.0% — and 2024, when it surged 440155028.21%.
  • Alvotech's Shares Outstanding (Weighted Average) stood at $13.5 million in 2021, then surged by 1770.37% to $252.2 million in 2022, then gained by 5.81% to $266.8 million in 2023, then increased by 13.11% to $301.8 million in 2024, then tumbled by 99.03% to $2.9 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $2.9 million (Q4 2025), $2.1 billion (Q3 2025), and $2.1 billion (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Alvotech 12.16 Mn -160.20 Mn -22.39 Mn 2.93 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.93 Mn
Sep 30, 2025 2.10 Bn
Jun 30, 2025 2.10 Bn
Mar 31, 2025 2.01 Bn
Dec 31, 2024 301.81 Mn
Sep 30, 2024 2.01 Bn
Jun 30, 2024 1.72 Bn
Mar 31, 2024 1.73 Bn
Dec 31, 2023 266.82 Mn
Jun 30, 2023 390.00
Mar 31, 2023 1.24 Bn
Dec 31, 2022 252.16 Mn
Jun 30, 2022 1.03 Bn
Dec 31, 2021 13.48 Mn
Dec 31, 2020 7.26 Mn